Cullinan Oncology Inc
NASDAQ:CGEM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cullinan Oncology Inc
NASDAQ:CGEM
|
US |
|
L
|
Lamda Development SA
ATHEX:LAMDA
|
GR |
|
Andean Silver Ltd
ASX:ASL
|
AU |
|
Opus Genetics Inc
NASDAQ:IRD
|
US |
|
Deceuninck NV
LSE:0MEL
|
BE |
|
Unitil Corp
NYSE:UTL
|
US |
|
O
|
OSK Holdings Bhd
KLSE:OSK
|
MY |
|
Waterstone Financial Inc
NASDAQ:WSBF
|
US |
|
S
|
SG Capital PCL
SET:SGC
|
TH |
|
Farmmi Inc
NASDAQ:FAMI
|
CN |
|
Freehold Royalties Ltd
TSX:FRU
|
CA |
Wall Street
Price Targets
CGEM Price Targets Summary
Cullinan Oncology Inc
According to Wall Street analysts, the average 1-year price target for
CGEM
is 34.43 USD
with a low forecast of 24.24 USD and a high forecast of 55.65 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CGEM's stock price target?
Price Target
34.43
USD
According to Wall Street analysts, the average 1-year price target for
CGEM
is 34.43 USD
with a low forecast of 24.24 USD and a high forecast of 55.65 USD.